ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Nephrology

Top Nephrology Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEVEN POLLAK M.D.

Nephrology

1,608

$289K

117
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 31%

$180
Average prescription price

Avg: $135

RATNA YADLA M.D

Nephrology

1,236

$210K

49
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 31%

$170
Average prescription price

Avg: $135

MOGES GEBREMARIAM MD

Nephrology

1,031

$169K

105
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 31%

$164
Average prescription price

Avg: $135

JONATHAN RUDICK MD

Nephrology

879

$197K

94
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$225
Average prescription price

Avg: $135

ELI ROZA MD

Nephrology

5,442

$811K

265
180 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 31%

$149
Average prescription price

Avg: $135

BABAK RAZI MD

Nephrology

2,925

$542K

149
58 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$185
Average prescription price

Avg: $135

BUARI OSMAN MD

Nephrology

2,145

$424K

180
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 31%

$197
Average prescription price

Avg: $135

SAEED KRONFLI M.D.

Nephrology

1,147

$285K

143
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 31%

$248
Average prescription price

Avg: $135

JOHN DALTON M.D.

Nephrology

4,378

$277K

169
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 31%

$63
Average prescription price

Avg: $135

ATUL KATYAL MD

Nephrology

1,494

$165K

109
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 31%

$111
Average prescription price

Avg: $135

KHOSROW DAVACHI MD

Nephrology

8,951

$531K

353
207 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$59
Average prescription price

Avg: $135

NAVNEET AHUJA M.D.

Nephrology

936

$207K

118
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 31%

$221
Average prescription price

Avg: $135

ANDREW NOWAKOWSKI M.D.

Nephrology

2,661

$267K

224
143 are 65+

20%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$100
Average prescription price

Avg: $135

MARTIN GAVIN D.O.

Nephrology

899

$57.2K

115
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 31%

$64
Average prescription price

Avg: $135

MUNEEB MALIK M.D.

Nephrology

1,204

$128K

203
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 31%

$106
Average prescription price

Avg: $135

BARRY HECHT M.D.

Nephrology

2,927

$261K

227
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$89
Average prescription price

Avg: $135

ROBERT WELIK MD PA

Nephrology

8,340

$1.01M

407
314 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$121
Average prescription price

Avg: $135

FARZAD ASSAR M.D.

Nephrology

4,205

$338K

151
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$80
Average prescription price

Avg: $135

ONEY ZUNIGA MD

Nephrology

8,206

$648K

223
170 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 31%

$79
Average prescription price

Avg: $135

PHILIP SCHWARTZ M.D.

Nephrology

2,242

$280K

199
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 31%

$125
Average prescription price

Avg: $135

VICTOR ONYEJIAKA MD

Nephrology

5,052

$302K

110
76 are 65+

25%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 31%

$60
Average prescription price

Avg: $135

TANUJA MISHRA MD

Nephrology

1,503

$80.5K

258
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 31%

$54
Average prescription price

Avg: $135

GAIL SEIKEN M.D.

Nephrology

813

$175K

77
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 31%

$215
Average prescription price

Avg: $135

ANURADHA BODDETI M.D.

Nephrology

955

$165K

150
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 31%

$173
Average prescription price

Avg: $135

ANISH HINDUJA MD

Nephrology

2,701

$316K

183
126 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 31%

$117
Average prescription price

Avg: $135

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank